MoonLake Immunotherapeutics (MLTX)
17.69
+0.20
(+1.14%)
USD |
NASDAQ |
Jun 11, 16:00
17.41
-0.28
(-1.58%)
After-Hours: 19:35
MoonLake Immunotherapeutics Max Drawdown (5Y) : 90.22% for May 31, 2026
Max Drawdown (5Y) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| May 31, 2026 | 90.22% |
| April 30, 2026 | 90.22% |
| March 31, 2026 | 90.22% |
| February 28, 2026 | 90.22% |
| January 31, 2026 | 90.22% |
| December 31, 2025 | 90.22% |
| November 30, 2025 | 90.22% |
| October 31, 2025 | 90.22% |
| September 30, 2025 | 90.22% |
| August 31, 2025 | 64.60% |
| July 31, 2025 | 64.60% |
| June 30, 2025 | 64.60% |
| May 31, 2025 | 64.60% |
| April 30, 2025 | 64.60% |
| March 31, 2025 | 64.60% |
| February 28, 2025 | 64.60% |
| January 31, 2025 | 64.60% |
| December 31, 2024 | 64.60% |
| November 30, 2024 | 64.60% |
| October 31, 2024 | 64.60% |
| September 30, 2024 | 64.60% |
| August 31, 2024 | 64.60% |
| July 31, 2024 | 64.60% |
| June 30, 2024 | 64.60% |
| May 31, 2024 | 64.60% |
| Date | Value |
|---|---|
| April 30, 2024 | 64.60% |
| March 31, 2024 | 64.60% |
| February 29, 2024 | 64.60% |
| January 31, 2024 | 64.60% |
| December 31, 2023 | 64.60% |
| November 30, 2023 | 64.60% |
| October 31, 2023 | 64.60% |
| September 30, 2023 | 64.60% |
| August 31, 2023 | 64.60% |
| July 31, 2023 | 64.60% |
| June 30, 2023 | 64.60% |
| May 31, 2023 | 64.60% |
| April 30, 2023 | 64.60% |
| March 31, 2023 | 64.60% |
| February 28, 2023 | 64.60% |
| January 31, 2023 | 64.60% |
| December 31, 2022 | 64.60% |
| November 30, 2022 | 64.60% |
| October 31, 2022 | 64.60% |
| September 30, 2022 | 64.60% |
| August 31, 2022 | 64.60% |
| July 31, 2022 | 64.60% |
| June 30, 2022 | 64.60% |
| May 31, 2022 | 64.60% |
| April 30, 2022 | 63.40% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| BeOne Medicines Ltd. | 69.96% |
| AC Immune SA | 89.55% |
| CRISPR Therapeutics AG | 85.11% |
| Idorsia Ltd. | 97.99% |
| ADC Therapeutics SA | 99.08% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -0.6529 |
| Beta (5Y) | 1.039 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 81.95% |
| Historical Sharpe Ratio (5Y) | 0.1267 |
| Historical Sortino (5Y) | 0.1688 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 25.49% |